Alchem Laboratories

Executive Summary

Alchem Laboratories Corporation, founded in 1978 and headquartered in Alachua, Florida, is a privately-held biopharmaceutical company specializing in antiviral therapeutics and antibody-based treatments for infectious diseases. The company leverages its deep expertise in custom synthesis and high-throughput screening to develop innovative therapies. Additionally, Alchem has a substantial track record in manufacturing active pharmaceutical ingredients (APIs) and drug products for numerous clinical trials across various therapeutic areas, positioning it as a versatile contract development and manufacturing organization (CDMO) as well as a drug developer. While the company lacks publicly traded securities, its long-standing presence and technical capabilities suggest a steady, if understated, role in the biopharma ecosystem.

Upcoming Catalysts (preview)

• TBDAnnouncement of new clinical trial or partnership for antiviral/antibody pipeline50% success
• TBDExpansion or new FDA approval of manufacturing facility to increase CDMO capacity60% success
• TBDDisclosure of financial results or funding round highlighting growth and valuation40% success